Lumexa Imaging (NASDAQ:LMRI) Hits New 12-Month Low - Time to Sell?

Key Points

• Lumexa Imaging hit a new 52-week low, trading as low as $8.40 and last at $9.99 (prior close $11.06) on volume of about 35,148 shares.
• Analysts remain bullish: Raymond James upgraded the stock to a "strong-buy" with a $23 price target, and the MarketBeat consensus rating is "Strong Buy" with an average target of $23.
• Institutional interest is rising, as several firms (including Oxford Asset Management, Hudson Bay, Barclays and others) established new stakes in the fourth quarter, the largest reported around $670,000.

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI - Get Free Report) shares reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $8.40 and last traded at $9.9880, with a volume of 35148 shares traded. The stock had previously closed at $11.06.

Analysts Set New Price Targets

Separately, Raymond James Financial raised shares of Lumexa Imaging from an "outperform" rating to a "strong-buy" rating and set a $23.00 price objective on the stock in a report on Monday, February 9th. One equities research analyst has rated the stock with a Strong Buy rating, According to MarketBeat, the stock has an average rating of "Strong Buy" and an average target price of $23.00.

Lumexa Imaging Price Performance

The stock has a fifty day moving average price of $13.69.

Hedge Funds Weigh In On Lumexa Imaging

Several large investors have recently made changes to their positions in the company. Assetmark Inc. acquired a new stake in Lumexa Imaging during the fourth quarter valued at $36,000. Barclays PLC purchased a new stake in shares of Lumexa Imaging during the 4th quarter worth about $133,000. Sandia Investment Management LP purchased a new stake in shares of Lumexa Imaging during the 4th quarter worth about $185,000. Hudson Bay Capital Management LP acquired a new stake in shares of Lumexa Imaging during the 4th quarter valued at about $237,000. Finally, Oxford Asset Management LLP purchased a new position in shares of Lumexa Imaging in the 4th quarter valued at about $670,000.

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.